Sithu Win, MD, MPH
Associate Professor
Medicine
School of Medicine

Publications (16)

Top publication keywords:
EchocardiographyPneumonia, BacterialHeart FailurePatient ReadmissionRegistriesElectrocardiography, AmbulatoryArrhythmogenic Right Ventricular DysplasiaCocaineRisk AssessmentInpatientsCocaine-Related DisordersOregonVentricular Function, RightPericardial EffusionStroke Volume

• Formative research to adapt a cardiac rehabilitation program to breast cancer survivors: the heart health after cancer treatment (HEART-ACT) study.
  Cardio-oncology (London, England) 2024 Chang A, Boyd A, Leung I, Trejo E, Dixit N, Mallidi J, Win S, Beatty AL
• Cocaine Use is Associated With Increased LVMI in Unstably Housed Women With Polysubstance Use.
  Substance abuse 2023 Ravi A, Vittinghoff E, Wu AHB, Suen LW, Coffin PO, Hsue P, Lynch KL, Win S, Kazi DS, Riley ED
• Reduced exercise capacity, chronotropic incompetence, and early systemic inflammation in cardiopulmonary phenotype Long COVID.
  medRxiv : the preprint server for health sciences 2023 Durstenfeld MS, Peluso MJ, Kaveti P, Hill C, Li D, Sander E, Swaminathan S, Arechiga VM, Lu S, Goldberg SA, Hoh R, Chenna A, Yee BC, Winslow JW, Petropoulos CJ, Kelly JD, Glidden DV, Henrich TJ, …
• Rate-Adaptive Atrial Pacing for Heart Failure With Preserved Ejection Fraction: The RAPID-HF Randomized Clinical Trial.
  JAMA 2023 Reddy YNV, Koepp KE, Carter R, Win S, Jain CC, Olson TP, Johnson BD, Rea R, Redfield MM, Borlaug BA
• Association of Right Ventricular Dilation on Echocardiogram With In-Hospital Mortality Among Patients Hospitalized With COVID-19 Compared With Bacterial Pneumonia.
  Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography 2022 Sun K, Cedarbaum E, Hill CA, Win S, Parikh NI, Hsue PY, Durstenfeld MS

Show all (11 more) Hide

• Early identification of patients with Chagas disease at risk of developing cardiomyopathy using 2-D speckle tracking strain: Win, Miranda prediction of Chagas cardiomyopathy.
  International journal of cardiology. Heart & vasculature 2022 Win S, Miranda-Schaeubinger M, Gustavo Durán Saucedo R, Carballo Jimenez P, Flores J, Mercado-Saavedra B, Camila Telleria L, Raafs A, Verastegui M, Bern C, Tinajeros F, Heymans S, Marcus R, Gilman RH,…
• Outcomes in Patients With Heart Failure Using Cocaine.
  The American journal of cardiology 2022 Garry JD, Thakkar AB, Durstenfeld MS, Ma Y, Win S, Hsue PY
• Role of antibodies, inflammatory markers, and echocardiographic findings in postacute cardiopulmonary symptoms after SARS-CoV-2 infection.
  JCI insight 2022 Durstenfeld MS, Peluso MJ, Kelly JD, Win S, Swaminathan S, Li D, Arechiga VM, Zepeda V, Sun K, Shao S, Hill C, Arreguin MI, Lu S, Hoh R, Tai V, Chenna A, Yee BC, Winslow JW, Petropoulos CJ, Kornak J, …
• Prospective arrhythmia surveillance after a COVID-19 diagnosis.
  Open heart 2022 Dewland TA, Whitman IR, Win S, Sanchez JM, Olgin JE, Pletcher MJ, Santhosh L, Kumar U, Joyce S, Yang V, Hwang J, Ogomori K, Peyser N, Horner C, Wen D, Butcher X, Marcus GM
• Right Ventricular Strain Predicts Structural Disease Progression in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy.
  Journal of the American Heart Association 2020 Malik N, Win S, James CA, Kutty S, Mukherjee M, Gilotra NA, Tichnell C, Murray B, Agafonova J, Tandri H, Calkins H, Hays AG
• Inpatient Mortality Risk Scores and Postdischarge Events in Hospitalized Heart Failure Patients: A Community-Based Study.
  Circulation. Heart failure 2017 Win S, Hussain I, Hebl VB, Dunlay SM, Redfield MM
• Clinical and Echocardiographic Characteristics and Cardiovascular Outcomes According to Diabetes Status in Patients With Heart Failure and Preserved Ejection Fraction: A Report From the I-Preserve Trial (Irbesartan in Heart Failure With Preserved Ejection Fraction).
  Circulation 2017 Kristensen SL, Mogensen UM, Jhund PS, Petrie MC, Preiss D, Win S, Køber L, McKelvie RS, Zile MR, Anand IS, Komajda M, Gottdiener JS, Carson PE, McMurray JJ
• The Hospitalization Burden and Post-Hospitalization Mortality Risk in Heart Failure With Preserved Ejection Fraction: Results From the I-PRESERVE Trial (Irbesartan in Heart Failure and Preserved Ejection Fraction).
  JACC. Heart failure 2015 Carson PE, Anand IS, Win S, Rector T, Haass M, Lopez-Sendon J, Miller A, Teerlink JR, White M, McKelvie RS, Komajda M, Zile MR, McMurray JJ, Massie B
• History of atrial fibrillation as a risk factor in patients with heart failure and preserved ejection fraction.
  Circulation. Heart failure 2014 Oluleye OW, Rector TS, Win S, McMurray JJ, Zile MR, Komajda M, McKelvie RS, Massie B, Carson PE, Anand IS
• HAS-BLED and CHA₂DS₂-VASc scores as predictors of bleeding and thrombotic risk after continuous-flow ventricular assist device implantation.
  Journal of cardiac failure 2014 Koene RJ, Win S, Naksuk N, Adatya SN, Rosenbaum AN, John R, Eckman PM
• Effect of fixed-dose combination of isosorbide dinitrate and hydralazine on all hospitalizations and on 30-day readmission rates in patients with heart failure: results from the African-American Heart Failure Trial.
  Circulation. Heart failure 2014 Anand IS, Win S, Rector TS, Cohn JN, Taylor AL